CA
NZ
UK
AU
IND
US
● ClearPoint Neuro shares plunged on Tuesday, September 29, 2026, with a similar slide already visible in premarket trading.
● ClearPoint Neuro shares fell steeply on Tuesday, September 29, 2026, with a similar drop shown before the opening bell.
● Maravai LifeSciences fell on Tuesday, September 29, 2026, and the move was attributed to profit-taking after a rapid run-up.
● Immix released interim NEXICART-2 data on NXC-201 in relapsed or refractory AL amyloidosis on September 29, 2026.
● Summit Therapeutics shares soared on September 29, 2026, closing at $17.96 after AstraZeneca agreed to a $2 billionEquityinvestment.
● Summit Therapeutics closed at $17.96 on Tuesday, September 29, 2026, after AstraZeneca agreed to a $2 billion strategicEquityinvestment.
● AbbVie shares slipped to about $263.54 on Tuesday, September 29, 2026, as investors digested an FDA approval.
● The FDA set a December 22, 2026 target action date for lorundrostat in adults with hypertension.
● The FDA issued warning letters to Neogen and contract manufacturer Sciarra Aeromed over fungal contamination in Neogen Vet HYCOAT.
● GeneDx shares closed at $75.79 on Tuesday, September 29, down 11.80% from the prior close of $85.93.
Please wait processing your request...